Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naif I Aljohani

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Blood Advances|June 3, 2026
Defining durability in SCD gene therapyNaif I Aljohani
Hematology (Amsterdam, Netherlands)|August 19, 2021
Role of folinic acid in methotrexate-based prophylaxis of graft-versus-host disease following hematopoietic stem cell transplantationNaif I AlJohani
British Journal of Haematology|July 5, 2026
Immortal time bias limits the conclusion that post-transplant hypomethylating agent maintenance improves outcomes in myelodysplastic syndromesNaif I AlJohani
Transplantation and Cellular Therapy|May 10, 2026
Mechanistic considerations and a clinical caveat regarding the cord-blood-specific signal of post-HSCT gilteritinib maintenanceNaif I AlJohani
Epidemiology and Infection|November 29, 2021
Effect of non-pharmacological interventions on the COVID-19 epidemic in Saudi ArabiaNaif I AlJohani, Kipkoech Mutai
International Medical Case Reports Journal|March 5, 2014
Acquired factor V inhibitor in a patient with mantle cell lymphoma presenting with hematuria followed by thrombosis: a case reportNaif I Aljohani, John H Matthews
Ejhaem|July 18, 2022
What is the minimum adequate busulfan dose for patients with sickle cell disease undergoing reduced intensity conditioning with fludarabine, busulfan, and anti-thymocyte globulin?Naif I AlJohani, Amir Ahmed Toor
Journal of Medical Case Reports|September 18, 2015
Inclusion body myositis in a patient with chronic myeloid leukemia treated with dasatinib: a case reportNaif I AlJohani, Simon Carette, Jeffrey H Lipton
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|November 4, 2020
Lenalidomide-induced Interstitial PneumonitisAzhar Shafi, Jalil Ur Rehman, Azhar Nawaz, et al.
Hematology/Oncology and Stem Cell Therapy|December 11, 2020
Dose-adjusted bendamustine as a replacement for carmustine in autologous stem cell transplant conditioning for patients with relapsed lymphoma: A retrospective single-center studyNaif I AlJohani, Momen Nasani, Hosam E Ahmed, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Blood Advances|June 3, 2026
Defining durability in SCD gene therapyNaif I Aljohani
Hematology (Amsterdam, Netherlands)|August 19, 2021
Role of folinic acid in methotrexate-based prophylaxis of graft-versus-host disease following hematopoietic stem cell transplantationNaif I AlJohani
British Journal of Haematology|July 5, 2026
Immortal time bias limits the conclusion that post-transplant hypomethylating agent maintenance improves outcomes in myelodysplastic syndromesNaif I AlJohani
Transplantation and Cellular Therapy|May 10, 2026
Mechanistic considerations and a clinical caveat regarding the cord-blood-specific signal of post-HSCT gilteritinib maintenanceNaif I AlJohani
Epidemiology and Infection|November 29, 2021
Effect of non-pharmacological interventions on the COVID-19 epidemic in Saudi ArabiaNaif I AlJohani, Kipkoech Mutai
International Medical Case Reports Journal|March 5, 2014
Acquired factor V inhibitor in a patient with mantle cell lymphoma presenting with hematuria followed by thrombosis: a case reportNaif I Aljohani, John H Matthews
Ejhaem|July 18, 2022
What is the minimum adequate busulfan dose for patients with sickle cell disease undergoing reduced intensity conditioning with fludarabine, busulfan, and anti-thymocyte globulin?Naif I AlJohani, Amir Ahmed Toor
Journal of Medical Case Reports|September 18, 2015
Inclusion body myositis in a patient with chronic myeloid leukemia treated with dasatinib: a case reportNaif I AlJohani, Simon Carette, Jeffrey H Lipton
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|November 4, 2020
Lenalidomide-induced Interstitial PneumonitisAzhar Shafi, Jalil Ur Rehman, Azhar Nawaz, et al.
Hematology/Oncology and Stem Cell Therapy|December 11, 2020
Dose-adjusted bendamustine as a replacement for carmustine in autologous stem cell transplant conditioning for patients with relapsed lymphoma: A retrospective single-center studyNaif I AlJohani, Momen Nasani, Hosam E Ahmed, et al.
Pageof 2